rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Simba Gill

Director

Company insider

Files Form 4 as: Director, Foghorn Therapeutics; Director, Serina Therapeutics; President & CEO, Evelo Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
35
Buys
0
Sells
4
Bought
$0
Sold
$12K
Companies
3
Companies where not an officer
2
First trade
8 May 2018
Last trade
24 Jun 2026
Last filed
25 Jun 2026

Companies traded

Where they are an officer
Evelo BiosciencesDirector, Officer · last 8 Nov 20230 buys · 4 sells
Everywhere else they filed: board seats, 10% stakes, other companies
FHTX Foghorn TherapeuticsDirector · Biotechnology · last 24 Jun 20260 buys · 0 sells
SER Serina TherapeuticsDirector · Biotechnology · last 3 Feb 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Jun 2026filed 25 Jun 2026FHTX Foghorn Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$114K28,000 at $4.08filing
24 Jun 2026filed 25 Jun 2026FHTX Foghorn Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$114K28,000 at $4.08filing
3 Feb 2026filed 17 Feb 2026SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—92,000 at $0.00filing
3 Feb 2026filed 17 Feb 2026SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—92,000 at $0.00filing
17 Jun 2025filed 17 Jun 2025FHTX Foghorn Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$120K25,000 at $4.79filing
26 Jun 2024filed 28 Jun 2024FHTX Foghorn Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$88K16,000 at $5.52filing
15 Apr 2024filed 17 Apr 2024SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—295,300 at $0.00filing
8 Nov 2023filed 8 Nov 2023Evelo BiosciencesSEC FORM 4 Sold$57172 at $0.33filing
7 Nov 2023filed 8 Nov 2023Evelo Biosciencesoption or derivativeSEC FORM 4 Code M—1,172 at $0.00filing
7 Nov 2023filed 8 Nov 2023Evelo BiosciencesSEC FORM 4 Code M—1,172filing
28 Sep 2023filed 29 Sep 2023Evelo BiosciencesSEC FORM 4 Sold$7,8641,996 at $3.94filing
27 Sep 2023filed 29 Sep 2023Evelo Biosciencesoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
27 Sep 2023filed 29 Sep 2023Evelo Biosciencesoption or derivativeSEC FORM 4 Code M—15,000 at $0.00filing
27 Sep 2023filed 29 Sep 2023Evelo BiosciencesSEC FORM 4 Code M—15,000filing
8 Aug 2023filed 9 Aug 2023Evelo BiosciencesSEC FORM 4 Sold$3,252342 at $9.51filing
7 Aug 2023filed 9 Aug 2023Evelo Biosciencesoption or derivativeSEC FORM 4 Code M—1,171 at $0.00filing
7 Aug 2023filed 9 Aug 2023Evelo BiosciencesSEC FORM 4 Code M—1,171filing
21 Jun 2023filed 22 Jun 2023FHTX Foghorn Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
8 Jun 2023filed 12 Jun 2023Evelo Biosciencesoption or derivativeSEC FORM 4 Code A—1,000,000 at $0.00filing
8 May 2023filed 10 May 2023Evelo BiosciencesSEC FORM 4 Sold$4603,537 at $0.13filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.